Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for bronchoscopy sedation and anxiety
ChiCTR2600125256Phase 4Not yet recruiting
- Sponsor
- Quzhou People's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in None (2 arms), sponsored by Quzhou People's Hospital. Primary endpoint: Preoperative Anxiety Score. Planned start May 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2600125256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125256.